Fidaxomicin is approved for the treatment of adults with Clostridium difficile-associated
diarrhea, many of whom have difficulty swallowing an intact
tablet. The study objective was to evaluate the stability and recovery of crushed
DIFICID(®) (
fidaxomicin) 200-mg
tablets dispersed in water, applesauce, or Ensure(®) brand liquid nutritional supplement, and to determine the recovery of
fidaxomicin from the administration of an aqueous dispersion of a crushed
DIFICID(®)
tablet through a nasogastric (NG) tube.
DIFICID(®)
tablets were crushed and dispersed in water, applesauce, or Ensure(®). The stability and recovery of
fidaxomicin were evaluated over 24 h in these vehicles. In a separate experiment, the ability to recover a full dose of
fidaxomicin when administering as an aqueous dispersion through an NG tube was assessed. When
DIFICID(®)
tablets were crushed and dispersed in water, the active ingredient,
fidaxomicin, was stable for up to 2 h at room temperature. Additionally, it was stable for up to 24 h in dispersions with applesauce or Ensure(®). Recovery of
fidaxomicin after crushing and dispersing in any of the three vehicles studied ranged from 95 to 108 %, which is within the normal range of individual
tablet variability. When crushed, dispersed in water, and administered through an NG tube, the average recovery of
fidaxomicin was 96 %. Stability and recovery of
fidaxomicin were confirmed when
DIFICID(®)
tablets were crushed and dispersed in water, applesauce, or Ensure(®). In addition, administration of an aqueous dispersion of a crushed
tablet through an NG tube is supported by acceptable recovery of
fidaxomicin.